-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[Pharmaceutical Network Industry News] Traditional Chinese medicine formula granules are made from single-flavored Chinese medicine pieces as raw materials, extracted and concentrated according to traditional standards, and processed into uniform specifications, uniform doses, and uniform quality standards for use in traditional Chinese medicine clinical formulas
.
According to the research report of Founder Securities, the replacement rate of Chinese herbal formula granules for decoction pieces is expected to be 8-10%, and the replacement rate for Japan and South Korea is 60%, and the penetration rate has a large room for improvement
.
Many institutions predict that by 2030, the market size of traditional Chinese medicine granules will reach 100 billion yuan
.
At present, it has been nearly five months since the pilot of traditional Chinese medicine formula granules ended.
How are the pharmaceutical companies rushing to the beach? According to relevant data statistics, as of the first ten days of March 2022, there were 37 registered manufacturers of traditional Chinese medicine granules (by group) in China, involving 21 provinces (autonomous regions and municipalities) and 4,968 varieties
.
Among them, a number of manufacturers have more than 100 registered varieties, including China Traditional Chinese Medicine, Tianjin Hongri, Hunan Xinhui, China Resources Sanjiu, Sichuan New Green,
etc.
Among them, 10 subsidiaries of China Traditional Chinese Medicine, including Guangdong Yifang and Jiangyin Tianjiang, have accumulated more than 1,000 varieties of traditional Chinese medicine formula granules, up to 1,230
.
It can be seen that the company's determination to enter the formula granule industry
.
According to the data, the main business of China Traditional Chinese Medicine Holdings Co.
, Ltd.
is the research and development, production and sales of traditional Chinese medicines and pharmaceutical products
.
In the field of traditional Chinese medicine formula granules, the company has strong production strength.
At the same time, in terms of quality control, it adopts modern fingerprint analysis technology to implement quality monitoring from raw medicinal materials, intermediate products to finished products.
In the direction of integrated development, a relatively complete industrial chain of raw materials, research and development, production, circulation and terminal has been formed
.
It is worth mentioning that Tianjiang Pharmaceutical and Guangdong Yifang Pharmaceutical, both subsidiaries of China Traditional Chinese Medicine, are the first batch of independent research and development enterprises of traditional Chinese medicine formula granules in China, with large production scale, high degree of specialized production, strong research and development strength, and wide market coverage
.
Judging from the number of varieties of traditional Chinese medicine formula granules filed, both companies have more than 200, 302 and 219 respectively
.
Tianjin Hongri has 314 registrations after Chinese traditional medicine.
The company owns the former national pilot enterprises Beijing Kangrentang, Henan Hongri Kangrentang and Gansu Foci Hongri, with 268 and 45 varieties registered respectively.
, 1
.
It is understood that Tianjin Hongri has first-mover advantages in participating in the formulation of industry standards, industrial chain layout, varieties, channels and quality.
The company has established production bases in Beijing, Tianjin, Gansu, Hubei, Henan, Chongqing, Hebei and Shandong
.
In addition to the above two companies, Liaoning Good Nursing (298), Anhui Jiuzhou Fangyuan (279), Hunan Xinhui (262), and China Resources Sanjiu (209) also performed well, with more than 200 filings
.
In addition, there are more than 100 varieties of traditional Chinese medicine formula granules registered by a number of enterprises, including Yiling, Tiandi Hengyi, Chunguang Jiuhui, Shenwei Group, Jilin Aodong, Sichuan New Green,
etc.
Judging from the provinces where the above-mentioned enterprises are located, Hunan Province has the highest number of registered varieties, with a total of 620 varieties filed; followed by Guangdong, with 519 filings; Hubei and Beijing followed closely with 519 and 481 respectively.
1 and 440 varieties of formula granules were filed
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
.
According to the research report of Founder Securities, the replacement rate of Chinese herbal formula granules for decoction pieces is expected to be 8-10%, and the replacement rate for Japan and South Korea is 60%, and the penetration rate has a large room for improvement
.
Many institutions predict that by 2030, the market size of traditional Chinese medicine granules will reach 100 billion yuan
.
At present, it has been nearly five months since the pilot of traditional Chinese medicine formula granules ended.
How are the pharmaceutical companies rushing to the beach? According to relevant data statistics, as of the first ten days of March 2022, there were 37 registered manufacturers of traditional Chinese medicine granules (by group) in China, involving 21 provinces (autonomous regions and municipalities) and 4,968 varieties
.
Among them, a number of manufacturers have more than 100 registered varieties, including China Traditional Chinese Medicine, Tianjin Hongri, Hunan Xinhui, China Resources Sanjiu, Sichuan New Green,
etc.
Among them, 10 subsidiaries of China Traditional Chinese Medicine, including Guangdong Yifang and Jiangyin Tianjiang, have accumulated more than 1,000 varieties of traditional Chinese medicine formula granules, up to 1,230
.
It can be seen that the company's determination to enter the formula granule industry
.
According to the data, the main business of China Traditional Chinese Medicine Holdings Co.
, Ltd.
is the research and development, production and sales of traditional Chinese medicines and pharmaceutical products
.
In the field of traditional Chinese medicine formula granules, the company has strong production strength.
At the same time, in terms of quality control, it adopts modern fingerprint analysis technology to implement quality monitoring from raw medicinal materials, intermediate products to finished products.
In the direction of integrated development, a relatively complete industrial chain of raw materials, research and development, production, circulation and terminal has been formed
.
It is worth mentioning that Tianjiang Pharmaceutical and Guangdong Yifang Pharmaceutical, both subsidiaries of China Traditional Chinese Medicine, are the first batch of independent research and development enterprises of traditional Chinese medicine formula granules in China, with large production scale, high degree of specialized production, strong research and development strength, and wide market coverage
.
Judging from the number of varieties of traditional Chinese medicine formula granules filed, both companies have more than 200, 302 and 219 respectively
.
Tianjin Hongri has 314 registrations after Chinese traditional medicine.
The company owns the former national pilot enterprises Beijing Kangrentang, Henan Hongri Kangrentang and Gansu Foci Hongri, with 268 and 45 varieties registered respectively.
, 1
.
It is understood that Tianjin Hongri has first-mover advantages in participating in the formulation of industry standards, industrial chain layout, varieties, channels and quality.
The company has established production bases in Beijing, Tianjin, Gansu, Hubei, Henan, Chongqing, Hebei and Shandong
.
In addition to the above two companies, Liaoning Good Nursing (298), Anhui Jiuzhou Fangyuan (279), Hunan Xinhui (262), and China Resources Sanjiu (209) also performed well, with more than 200 filings
.
In addition, there are more than 100 varieties of traditional Chinese medicine formula granules registered by a number of enterprises, including Yiling, Tiandi Hengyi, Chunguang Jiuhui, Shenwei Group, Jilin Aodong, Sichuan New Green,
etc.
Judging from the provinces where the above-mentioned enterprises are located, Hunan Province has the highest number of registered varieties, with a total of 620 varieties filed; followed by Guangdong, with 519 filings; Hubei and Beijing followed closely with 519 and 481 respectively.
1 and 440 varieties of formula granules were filed
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
